Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Telescope Therapeutics Appoints Myriam Lavoie As Chief Executive Officer

PRIVATEJul 31, 20269 days ago

Position

Chief Executive Officer

Company

Telescope Therapeutics

Myriam Lavoie
MontrealBiotechnologyHealth CareTherapeutics

Description

Telescope Therapeutics has appointed Myriam Lavoie as Chief Executive Officer, marking a significant leadership milestone. Lavoie brings over 20 years of experience in the biotechnology and pharmaceutical industries to her new role.

Company Information

Company

Telescope Therapeutics

Location

Montreal, Quebec, Canada

About

Telescope Therapeutics is a biotechnology company focused on developing innovative therapies for fibrosis, a major driver of organ failure affecting millions of patients worldwide. The company combines human disease-relevant induced pluripotent stem cell (iPSC) models with biosensor-based GPCR precision pharmacology to evaluate therapeutic candidates in real time and accelerate the discovery of novel medicines. Initially targeting heart and kidney fibrosis, Telescope Therapeutics is building a pipeline of therapies designed to address significant unmet medical needs.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Telescope Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.